Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Adverse drug reactionInosine triphosphate pyrophosphataseQ9BY32Not Available15167706; 15571265; 15973722
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityPurine nucleoside phosphorylaseP00491T781987818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityCytosolic 5'-nucleotidase 1AQ9BXI3Not Available7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Leukoencephalopathy17.13.02.0030.001436%
Leukopenia01.02.02.0010.017950%Not Available
Lip dry07.06.01.0030.001436%Not Available
Lipase increased13.05.01.0030.002154%
Lipoma16.18.01.001; 15.09.01.0010.001436%Not Available
Listeriosis11.02.11.0010.003590%Not Available
Listless19.04.04.003; 08.01.01.0120.001436%Not Available
Liver abscess09.01.11.001; 11.01.18.0010.002872%Not Available
Liver disorder09.01.08.0010.005026%Not Available
Liver function test abnormal13.03.01.0130.009334%Not Available
Local swelling08.01.03.0130.002872%Not Available
Loss of consciousness17.02.04.004--Not Available
Lower respiratory tract infection22.07.01.002; 11.01.09.0020.002872%Not Available
Lung consolidation22.01.02.0100.002154%Not Available
Lung disorder22.02.07.0010.004308%Not Available
Lung infiltration22.01.02.0040.005744%Not Available
Lymphadenitis01.09.01.0010.001436%Not Available
Lymphadenopathy01.09.01.0020.015796%Not Available
Lymphoma16.20.01.001; 01.12.01.0010.002622%Not Available
Lymphopenia01.02.02.0020.007898%Not Available
Macrocytosis01.07.02.0030.001436%Not Available
Malaise08.01.01.0030.035900%
Malignant melanoma23.08.01.001; 16.03.01.0010.007180%Not Available
Melanocytic naevus23.10.01.007; 16.26.01.0070.001436%Not Available
Meningitis17.06.03.001; 11.01.03.001--
Meningitis bacterial17.06.10.002; 11.02.01.0130.000375%Not Available
Metabolic acidosis14.01.01.003--Not Available
Metastases to liver16.22.02.001; 09.04.02.0040.000375%Not Available
Metastatic malignant melanoma23.08.01.002; 16.03.01.0020.000937%Not Available
Migraine24.03.05.003; 17.14.02.001--Not Available
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 27 Pages